Book contents
- Prescriber’s Guide – Children and Adolescents
- Prescriber’s Guide – Children and Adolescents
- Copyright page
- Contents
- Introduction
- List of icons
- Amphetamine-D
- Amphetamine-D,L
- Aripiprazole
- Asenapine
- Atomoxetine
- Bupropion
- Chlorpromazine
- Citalopram
- Clomipramine
- Clonidine
- Clozapine
- Duloxetine
- Escitalopram
- Fluoxetine
- Fluphenazine
- Fluvoxamine
- Guanfacine
- Haloperidol
- Lisdexamfetamine
- Lithium
- Lurasidone
- Methylphenidate-D
- Methylphenidate-D,L
- Olanzapine
- Paliperidone
- Paroxetine
- Pimozide
- Quetiapine
- Risperidone
- Sertraline
- Trazodone
- Valproate
- Venlafaxine
- Index by drug name (trade names and generic names)
- Index by use
- Index by class
- Abbreviations
- Endmatter
- References
Asenapine
Published online by Cambridge University Press: 19 October 2021
Book contents
- Prescriber’s Guide – Children and Adolescents
- Prescriber’s Guide – Children and Adolescents
- Copyright page
- Contents
- Introduction
- List of icons
- Amphetamine-D
- Amphetamine-D,L
- Aripiprazole
- Asenapine
- Atomoxetine
- Bupropion
- Chlorpromazine
- Citalopram
- Clomipramine
- Clonidine
- Clozapine
- Duloxetine
- Escitalopram
- Fluoxetine
- Fluphenazine
- Fluvoxamine
- Guanfacine
- Haloperidol
- Lisdexamfetamine
- Lithium
- Lurasidone
- Methylphenidate-D
- Methylphenidate-D,L
- Olanzapine
- Paliperidone
- Paroxetine
- Pimozide
- Quetiapine
- Risperidone
- Sertraline
- Trazodone
- Valproate
- Venlafaxine
- Index by drug name (trade names and generic names)
- Index by use
- Index by class
- Abbreviations
- Endmatter
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Prescriber's Guide – Children and AdolescentsStahl's Essential Psychopharmacology, pp. 55 - 68Publisher: Cambridge University PressPrint publication year: 2018
References
Findling, RL, Landbloom, RL, Szegedi, A et al. Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder. J Am Acad Child Adolesc Psychiatry 2015; 54(12):1032–41.Google Scholar
Findling, RL, Landbloom, RL, Mackle, M et al. Long-term safety of asenapine in pediatric patients diagnosed with bipolar I disorder: a 50-week open-label, flexible-dose trial. Paediatr Drugs 2016;18(5):367–78.Google Scholar
Pagsberg, AK, Tarp, S, Glintborg, D et al. Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis. J Am Acad Child Adolesc Psychiatry 2017;56(3):191–202.Google Scholar
Pillay, J, Boylan, K, Carrey, N et al. First- and second-generation antipsychotics in children and young adults: systematic review update [internet]. Comparative Effectiveness Reviews. AHRQ Publication No. 17-EHC001-EF. Rockville, MD: Agency for Healthcare Research and Quality; March 2017.Google Scholar